siRNAs: their potential as therapeutic agents - Part II. Methods of delivery

Drug Discovery Today

Volumn 14, Issue 17-18, 2009, Pages 859-865

  Singh, Sunit Kumar ^a   Hajeri, Praveensingh B ^a  

^a CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; BACULOVIRUS VECTOR; DOUBLE STRANDED RNA; HERPESVIRUS VECTOR; LENTIVIRUS VECTOR; LIPID; LIPOPLEX; LIPOSOME; PARVOVIRUS VECTOR; RETROVIRUS VECTOR; SHORT HAIRPIN RNA; SMALL INTERFERING RNA;

BLADDER CANCER; CANCER INHIBITION; ENCAPSULATION; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE SILENCING; GENE TARGETING; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGENICITY; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PACHYONYCHIA; PLASMID; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; RNA INTERFERENCE; RNA VIRUS INFECTION; SUBRETINAL NEOVASCULARIZATION; TUMOR XENOGRAFT; VIRAL GENE DELIVERY SYSTEM;

DRUG DELIVERY SYSTEMS; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 69549119978     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drudis.2009.06.002     Document Type: Review

References (128)

1. Aigner A. Nonviral in vivo delivery of therapeutic small interfering RNAs. Curr. Opin. Mol. Ther. 9 (2007) 345-352
2. Hou J.Q., et al. Effect of small interfering RNA targeting survivin gene on biological behaviour of bladder cancer. Chin. Med. J. (Engl.) 119 (2006) 1734-1739
3. Reich S.J., et al. Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model. Mol. Vis. 9 (2003) 210-216
4. Thakker D.R., et al. siRNA-mediated knockdown of the serotonin transporter in the adult mouse brain. Mol. Psychiatry 10 (2005) 782-789 714
5. Dorn G., et al. siRNA relieves chronic neuropathic pain. Nucleic Acids Res. 32 (2004) e49
6. Zhang X., et al. Small interfering RNA targeting heme oxygenase-1 enhances ischemia-reperfusion-induced lung apoptosis. J. Biol. Chem. 279 (2004) 10677-106847
7. Bitko V., et al. Inhibition of respiratory viruses by nasally administered siRNA. Nat. Med. 11 (2005) 50-55
8. Zender L., et al. Caspase 8 small interfering RNA prevents acute liver failure in mice. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 7797-7802
9. Song E., et al. RNA interference targeting Fas protects mice from fulminant hepatitis. Nat. Med. 9 (2003) 347-351
10. Sioud M. Single-stranded small interfering RNA are more immunostimulatory than their double-stranded counterparts: a central role for 2′-hydroxyl uridines in immune responses. Eur. J. Immunol. 36 (2006) 1222-1230
11. Sioud M. Induction of inflammatory cytokines and interferon responses by double-stranded and single-stranded siRNAs is sequence-dependent and requires endosomal localization. J. Mol. Biol. 348 (2005) 1079-1090
12. Brummelkamp T.R., et al. A system for stable expression of short interfering RNAs in mammalian cells. Science 296 (2002) 550-553
13. Zeng Y., et al. Recognition and cleavage of primary microRNA precursors by the nuclear processing enzyme Drosha. EMBO J. 24 (2005) 138-148
14. Tabara H., et al. RNAi in C. elegans: soaking in the genome sequence. Science 282 (1998) 430-431
15. Timmons L., and Fire A. Specific interference by ingested dsRNA. Nature 395 (1998) 854
16. Vayssie L., et al. Double-stranded RNA mediates homology-dependent gene silencing of gamma-tubulin in the human parasite Entamoeba histolytica. Mol. Biochem. Parasitol. 138 (2004) 21-28
17. Soares C.A., et al. Capillary feeding of specific dsRNA induces silencing of the isac gene in nymphal Ixodes scapularis ticks. Insect. Mol. Biol. 14 (2005) 443-452
18. Patel A., et al. The making of a queen: TOR pathway is a key player in diphenic caste development. PLoS ONE 2 (2007) e509
19. Baum J.A., et al. Control of coleopteran insect pests through RNA interference. Nat. Biotechnol. 25 (2007) 1322-1326
20. Eaton B.A., et al. Dynactin is necessary for synapse stabilization. Neuron 34 (2002) 729-741
21. Clemens J.C., et al. Use of double-stranded RNA interference in Drosophila cell lines to dissect signal transduction pathways. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 6499-6503
22. Lum L., et al. Identification of Hedgehog pathway components by RNAi in Drosophila cultured cells. Science 299 (2003) 2039-2045
23. Yang D., et al. Short RNA duplexes produced by hydrolysis with Escherichia coli RNase III mediate effective RNA interference in mammalian cells. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 9942-9947
24. Myers J.W., et al. Recombinant Dicer efficiently converts large dsRNAs into siRNAs suitable for gene silencing. Nat. Biotechnol. 21 (2003) 324-328
25. Kittler R., et al. An endoribonuclease-prepared siRNA screen in human cells identifies genes essential for cell division. Nature 432 (2004) 1036-1040
26. Virieux C. The outcome of Hodgkin's disease associated with pregnancy. A study of 9 cases. Rev. Med. Suisse Romande 86 (1966) 821-839
27. Kittler R., and Buchholz F. Functional genomic analysis of cell division by endoribonuclease-prepared siRNAs. Cell Cycle 4 (2005) 564-567
28. Paddison P.J., et al. Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev. 16 (2002) 948-958
29. Peng Y., et al. shRNA driven by Pol II/T7 dual-promoter system effectively induce cell-specific RNA interference in mammalian cells. Biochem. Biophys. Res. Commun. 360 (2007) 496-500
30. Kamath R.S., et al. Effectiveness of specific RNA-mediated interference through ingested double-stranded RNA in Caenorhabditis elegans. Genome Biol. 2 (2001) RESEARCH0002
31. Issa Z., et al. Development of methods for RNA interference in the sheep gastrointestinal parasite, Trichostrongylus colubriformis. Int. J. Parasitol. 35 (2005) 935-940
32. Galvani A., and Sperling L. RNA interference by feeding in Paramecium. Trends Genet. 18 (2002) 11-12
33. Kuwahara A., et al. Delivery of dsRNA with lactic acid bacteria for RNA interference. Nucleic Acids Symp. Ser. (Oxf.) 51 (2007) 413-414
34. Isberg R.R., et al. Identification of invasin: a protein that allows enteric bacteria to penetrate cultured mammalian cells. Cell 50 5 (1987) 769-778
35. Courvalin P., et al. Gene transfer from bacteria to mammalian cells. C. R. Acad. Sci. III 318 (1995) 1207-1212
36. Grillot-Courvalin C., et al. Functional gene transfer from intracellular bacteria to mammalian cells. Nat. Biotechnol. 16 (1998) 862-866
37. Xiang S., et al. Short hairpin RNA-expressing bacteria elicit RNA interference in mammals. Nat. Biotechnol. 24 (2006) 697-702
38. Zhang L., et al. Intratumoral delivery and suppression of prostate tumor growth by attenuated Salmonella enterica serovar typhimurium carrying plasmid-based small interfering RNAs. Cancer Res. 67 (2007) 5859-5864
39. Gao G.P., et al. Biology of adenovirus vectors with E1 and E4 deletions for liver-directed gene therapy. J. Virol. 70 (1996) 8934-8943
40. Armentano D., et al. Effect of the E4 region on the persistence of transgene expression from adenovirus vectors. J. Virol. 71 (1997) 2408-2416
41. O'Neal W.K., et al. Toxicity associated with repeated administration of first-generation adenovirus vectors does not occur with a helper-dependent vector. Mol. Med. 6 (2000) 179-195
42. Schiedner G., et al. Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity. Nat. Genet. 18 (1998) 180-183
43. Shen C., et al. Gene silencing by adenovirus-delivered siRNA. FEBS Lett. 539 (2003) 111-114
44. Hosono T., et al. Adenovirus vector-mediated doxycycline-inducible RNA interference. Hum Gene Ther. 15 (2004) 813-819
45. Lieber A., et al. Integrating adenovirus-adeno-associated virus hybrid vectors devoid of all viral genes. J. Virol. 73 (1999) 9314-9324
46. Soifer H.S., and Kasahara N. Retrotransposon-adenovirus hybrid vectors: efficient delivery and stable integration of transgenes via a two-stage mechanism. Curr. Gene Ther. 4 (2004) 373-384
47. Erles K., et al. Update on the prevalence of serum antibodies (IgG and IgM) to adeno-associated virus (AAV). J. Med. Virol. 59 (1999) 406-411
48. Grimm D., and Kay M.A. From virus evolution to vector revolution: use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy. Curr. Gene Ther. 3 (2003) 281-304
49. Grimm D. Production methods for gene transfer vectors based on adeno-associated virus serotypes. Methods 28 (2002) 146-157
50. Stilwell J.L., and Samulski R.J. Role of viral vectors and virion shells in cellular gene expression. Mol. Ther. 9 (2004) 337-346
51. Heister T., et al. Herpes simplex virus type 1/adeno-associated virus hybrid vectors mediate site-specific integration at the adeno-associated virus preintegration site, AAVS1, on human chromosome 19. J. Virol. 76 (2002) 7163-7173
52. Palombo F., et al. Site-specific integration in mammalian cells mediated by a new hybrid baculovirus-adeno-associated virus vector. J. Virol. 7 (1998) 5025-5034
53. Girod A., et al. Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2. Nat. Med. 5 (1999) 1438
54. Fitzsimons H.L., et al. Insulators coupled to a minimal bidirectional tet cassette for tight regulation of rAAV-mediated gene transfer in the mammalian brain. Gene Ther. 8 (2001) 1675-1681
55. Yu J.Y., et al. Simultaneous inhibition of GSK3alpha and GSK3beta using hairpin siRNA expression vectors. Mol. Ther. 7 (2003) 228-236
56. Hommel J.D., et al. Local gene knockdown in the brain using viral-mediated RNA interference. Nat. Med. 9 (2003) 1539-1544
57. Boden D., et al. Efficient gene transfer of HIV-1-specific short hairpin RNA into human lymphocytic cells using recombinant adeno-associated virus vectors. Mol. Ther. 9 (2004) 396-402
58. Zhang W., et al. Attenuation of dengue virus infection by adeno-associated virus-mediated siRNA delivery. Genet Vaccines Ther. 2 (2004) 8
59. Chen C.C., et al. Long-term inhibition of hepatitis B virus in transgenic mice by double-stranded adeno-associated virus 8-delivered short hairpin RNA. Gene Ther. 14 (2007) 11-19
60. Barquinero J., et al. Retroviral vectors: new applications for an old tool. Gene Ther. 11 Suppl 1 (2004) S3-9
61. van der Loo J.C., et al. Optimization of gene transfer into primitive human hematopoietic cells of granulocyte-colony stimulating factor-mobilized peripheral blood using low-dose cytokines and comparison of a gibbon ape leukemia virus versus an RD114-pseudotyped retroviral vector. Hum. Gene Ther. 13 (2002) 1317-1330
62. Barton G.M., and Medzhitov R. Retroviral delivery of small interfering RNA into primary cells. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 14943-14945
63. Cronin J., et al. Altering the tropism of lentiviral vectors through pseudotyping. Curr. Gene Ther. 5 (2005) 387-398
64. Kafri T., et al. Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nat. Genet. 17 (1997) 314-317
65. Naldini L., et al. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 11382-11388
66. Rubinson D.A., et al. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat. Genet. 33 (2003) 401-406
67. Uchida N., et al. HIV, but not murine leukemia virus, vectors mediate high efficiency gene transfer into freshly isolated G0/G1 human hematopoietic stem cells. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 11939-11944
68. Li M.J., et al. Inhibition of HIV-1 infection by lentiviral vectors expressing Pol III-promoted anti-HIV RNAs. Mol. Ther. 8 (2003) 196-206
69. Qin X.F., et al. Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 183-188
70. Zufferey R., et al. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J. Virol. 72 (1998) 9873-9880
71. Abbas-Terki T., et al. Lentiviral-mediated RNA interference. Hum. Gene Ther. 13 (2002) 2197-2201
72. Root D.E., et al. Genome-scale loss-of-function screening with a lentiviral RNAi library. Nat. Methods 3 (2006) 715-719
73. Paddison P.J., et al. A resource for large-scale RNA-interference-based screens in mammals. Nature 428 (2004) 427-431
74. Moffat J., et al. A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell 124 (2006) 1283-1298
75. Sabbioni S., et al. Use of herpes simplex virus type 1-based amplicon vector for delivery of small interfering RNA. Gene Ther. 14 (2007) 459-464
76. Lambeth L.S., et al. Targeting Marek's disease virus by RNA interference delivered from a herpes virus vaccine. Vaccine 27 (2009) 298-306
77. Saydam O., et al. Herpes simplex virus 1 amplicon vector-mediated siRNA targeting epidermal growth factor receptor inhibits growth of human glioma cells in vivo. Mol. Ther. 12 (2005) 803-812
78. Samaniego L.A., et al. Persistence and expression of the herpes simplex virus genome in the absence of immediate-early proteins. J. Virol. 72 (1998) 3307-3320
79. Lu L., et al. Suppression of porcine arterivirus replication by baculovirus-delivered shRNA targeting nucleoprotein. Biochem. Biophys. Res. Commun. 340 (2006) 1178-1183
80. Suzuki H., et al. Suppression of hepatitis C virus replication by baculovirus vector-mediated short-hairpin RNA expression. FEBS Lett. 582 (2008) 3085-3089
81. Starkey J.L., et al. Hepatitis B virus (HBV)-specific short hairpin RNA is capable of reducing the formation of HBV covalently closed circular (CCC) DNA but has no effect on established CCC DNA in vitro. J. Gen. Virol. 90 Pt 1 (2009) 115-126
82. Nicholson L.J., et al. RNA interference mediated in human primary cells via recombinant baculoviral vectors. Mol. Ther. 11 (2005) 638-644
83. Nguyen T., et al. RNAi therapeutics: an update on delivery. Curr. Opin. Mol. Ther. 10 (2008) 158-167
84. Singh S.K. RNA interference and its therapeutic potential against HIV infection. Expert Opin. Biol. Ther. 8 (2008) 449-461
85. Shen J., et al. Suppression of ocular neovascularization with siRNA targeting VEGF receptor 1. Gene Ther. 13 (2006) 225-234
86. Li B.J., et al. Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque. Nat. Med. 11 (2005) 944-951
87. Luo M.C., et al. An efficient intrathecal delivery of small interfering RNA to the spinal cord and peripheral neurons. Mol. Pain 1 (2005) 29
88. Makimura H., et al. Reducing hypothalamic AGRP by RNA interference increases metabolic rate and decreases body weight without influencing food intake. BMC Neurosci. 3 (2002) 18
89. Akaneya Y., et al. RNAi-induced gene silencing by local electroporation in targeting brain region. J. Neurophysiol. 93 (2005) 594-602
90. Wang Q., et al. Delivery and inhibition of reporter genes by small interfering RNAs in a mouse skin model. J. Invest. Dermatol. 127 (2007) 2577-2584
91. Hickerson R.P., et al. Single-nucleotide-specific siRNA targeting in a dominant-negative skin model. J. Invest. Dermatol. 128 (2008) 594-605
92. Smith F.J., et al. Development of therapeutic siRNAs for pachyonychia congenita. J. Invest. Dermatol. 128 (2008) 50-58
93. Palliser D., et al. An siRNA-based microbicide protects mice from lethal herpes simplex virus 2 infection. Nature 439 (2006) 89-94
94. Soutschek J., et al. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature 432 (2004) 173-178
95. Wolfrum C., et al. Mechanisms and optimization of in vivo delivery of lipophilic siRNAs. Nat. Biotechnol. 25 (2007) 1149-1157
96. McNamara II J.O., et al. Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras. Nat. Biotechnol. 24 (2006) 1005-1015
97. Chu T.C., et al. Aptamer mediated siRNA delivery. Nucleic Acids Res. 34 (2006) e73
98. Kumar P., et al. Transvascular delivery of small interfering RNA to the central nervous system. Nature 448 (2007) 39-43
99. Hu-Lieskovan S., et al. Sequence-specific knockdown of EWS-FLI1 by targeted, nonviral delivery of small interfering RNA inhibits tumor growth in a murine model of metastatic Ewing's sarcoma. Cancer Res. 65 (2005) 8984-8992
100. Zatsepin T.S., et al. Conjugates of oligonucleotides and analogues with cell penetrating peptides as gene silencing agents. Curr. Pharm. Des. 11 (2005) 3639-3654
101. Simeoni F., et al. Insight into the mechanism of the peptide-based gene delivery system MPG: implications for delivery of siRNA into mammalian cells. Nucleic Acids Res. 31 (2003) 2717-2724
102. Kim W.J., et al. Cholesteryl oligoarginine delivering vascular endothelial growth factor siRNA effectively inhibits tumor growth in colon adenocarcinoma. Mol. Ther. 14 (2006) 343-350
103. Howard K.A., et al. RNA interference in vitro and in vivo using a novel chitosan/siRNA nanoparticle system. Mol. Ther. 14 (2006) 476-484
104. Heidel J.D., et al. Administration in non-human primates of escalating intravenous doses of targeted nanoparticles containing ribonucleotide reductase subunit M2 siRNA. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 5715-5721
105. Pille J.Y., et al. Intravenous delivery of anti-RhoA small interfering RNA loaded in nanoparticles of chitosan in mice: safety and efficacy in xenografted aggressive breast cancer. Hum. Gene Ther. 17 (2006) 1019-1026
106. Urban-Klein B., et al. RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo. Gene Ther. 12 (2005) 461-466
107. Ge Q., et al. Inhibition of influenza virus production in virus-infected mice by RNA interference. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 8676-8681
108. Song E., et al. Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors. Nat. Biotechnol. 23 (2005) 709-717
109. Santel A., et al. A novel siRNA-lipoplex technology for RNA interference in the mouse vascular endothelium. Gene Ther. 13 (2006) 1222-1234
110. Judge A.D., et al. Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA. Nat. Biotechnol. 23 (2005) 457-462
111. Zimmermann T.S., et al. RNAi-mediated gene silencing in non-human primates. Nature 441 (2006) 111-114
112. Nakamura H., et al. RNA interference targeting transforming growth factor-beta type II receptor suppresses ocular inflammation and fibrosis. Mol. Vis. 10 (2004) 703-711
113. Aouadi M., et al. Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation. Nature 458 (2009) 1180-1184
114. Kumar P., et al. T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice. Cell 134 (2008) 577-586
115. An D.S., et al. Stable reduction of CCR5 by RNAi through hematopoietic stem cell transplant in non-human primates. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 13110-13115
116. Van den Haute C., et al. Lentiviral vector-mediated delivery of short hairpin RNA results in persistent knockdown of gene expression in mouse brain. Hum. Gene Ther. 14 (2003) 1799-1807
117. Harper S.Q., et al. RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 5820-5825
118. Ralph G.S., et al. Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS model. Nat. Med. 11 (2005) 429-433
119. ter Brake O., et al. Lentiviral vector design for multiple shRNA expression and durable HIV-1 inhibition. Mol. Ther. 16 (2008) 557-564
120. Alves S., et al. Allele-specific RNA silencing of mutant ataxin-3 mediates neuroprotection in a rat model of Machado-Joseph disease. PLoS ONE 3 (2008) e3341
121. Hacein-Bey-Abina S., et al. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N. Engl. J. Med. 348 (2003) 255-256
122. Grimm D., et al. Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature 441 (2006) 537-541
123. Witting S.R., et al. Helper-dependent adenovirus-mediated short hairpin RNA expression in the liver activates the interferon response. J. Biol. Chem. 283 (2008) 2120-2128
124. de Jonge J., et al. Reconstituted influenza virus envelopes as an efficient carrier system for cellular delivery of small-interfering RNAs. Gene Ther. 13 (2006) 400-411
125. Arkema A., et al. Induction of cytotoxic T lymphocyte activity by fusion-active peptide-containing virosomes. Vaccine 18 (2000) 1327-1333
126. Bungener L., et al. Virosome-mediated delivery of protein antigens to dendritic cells. Vaccine 20 (2002) 2287-2295
127. Robbins M., et al. Misinterpreting the therapeutic effects of small interfering RNA caused by immune stimulation. Hum. Gene Ther. 19 (2008) 991-999
128. Kleinman M.E., et al. Sequence- and target-independent angiogenesis suppression by siRNA via TLR3. Nature 452 (2008) 591-597